- Home
- CLRB vs CTM Comparison
CLRB vs CTM Comparison
Compare CLRB & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- CTM
- Stock Information
- Founded
- CLRB 2002
- CTM 2019
- Country
- CLRB United States
- CTM United States
- Employees
- CLRB N/A
- CTM N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- CTM EDP Services
- Sector
- CLRB Health Care
- CTM Technology
- Exchange
- CLRB Nasdaq
- CTM Nasdaq
- Market Cap
- CLRB 10.7M
- CTM 9.4M
- IPO Year
- CLRB N/A
- CTM N/A
- Fundamental
- Price
- CLRB $0.24
- CTM $1.11
- Analyst Decision
- CLRB Buy
- CTM
- Analyst Count
- CLRB 2
- CTM 0
- Target Price
- CLRB $28.00
- CTM N/A
- AVG Volume (30 Days)
- CLRB 3.3M
- CTM 19.4M
- Earning Date
- CLRB 11-18-2024
- CTM 11-13-2024
- Dividend Yield
- CLRB N/A
- CTM N/A
- EPS Growth
- CLRB N/A
- CTM N/A
- EPS
- CLRB N/A
- CTM N/A
- Revenue
- CLRB N/A
- CTM $45,555,964.00
- Revenue This Year
- CLRB N/A
- CTM $29.25
- Revenue Next Year
- CLRB N/A
- CTM N/A
- P/E Ratio
- CLRB N/A
- CTM N/A
- Revenue Growth
- CLRB N/A
- CTM 3.12
- 52 Week Low
- CLRB $0.22
- CTM $0.12
- 52 Week High
- CLRB $4.45
- CTM $2.83
- Technical
- Relative Strength Index (RSI)
- CLRB 18.75
- CTM 53.59
- Support Level
- CLRB $0.27
- CTM $0.82
- Resistance Level
- CLRB $0.33
- CTM $1.08
- Average True Range (ATR)
- CLRB 0.03
- CTM 0.39
- MACD
- CLRB 0.05
- CTM -0.07
- Stochastic Oscillator
- CLRB 10.38
- CTM 20.96
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.